Update indirect rates and far & hhsar clauses on contract

Ended Definitive Contract Awarded Last action

Contract number
75A50118C00024
Awardee
Awarding agency
Obligated
$56,704,950

Award facts

Contract value 91% obligated
  • $56,704,950.00 Current, with exercised options
  • $62,511,942.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00026 $0
Supplemental Agreement for work within scope P00025 · Mapp biopharmaceutical, INC. - transfer GFP from contract HHSO100201800024C to contract 75A50122C00061 and update clauses on contract advance MBP134, a cocktail… $0
Supplemental Agreement for work within scope P00024 $0
Supplemental Agreement for work within scope P00023 $0
Supplemental Agreement for work within scope P00022 $0
Supplemental Agreement for work within scope P00021 $0
Supplemental Agreement for work within scope P00020 $0
Supplemental Agreement for work within scope P00019 $0
Additional Work (new agreement, FAR part 6 applies) P00018 $0
Supplemental Agreement for work within scope P00017 $0
Supplemental Agreement for work within scope P00016 $0
Supplemental Agreement for work within scope P00015 $868,179
Supplemental Agreement for work within scope P00014 $0
Other Administrative Action P00013 $0
Other Administrative Action P00012 · Advance MBP134, a cocktail of two human monoclonal antibodies (MBP047 and MBP087), as a potential medical countermeasure to treat active infections of sudan… $0
Funding Only Action P00011 · The purpose of this modification is to add additional funding for clin 0004. $916,688
Other Administrative Action P00010 · The purpose of this administrative modification is to add an alternate contracting officer's representative (ACOR) and update articles G.2. And G.5. $0
Other Administrative Action P00009 · The purpose of this administrative modification is to modify articles F.2 deliverables, G.1 contracting officer, G.5 invoice/finance request, G.7 indirect… $0
Exercise an Option P00008 $14,622,591
Other Administrative Action P00007 · Mapp biopharmaceitical: developement of anti-sudan ebolavirus MCM $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 · Revise statement of work; and provide supplemental funding $969,970
Other Administrative Action P00004 · Change in key personnel $0
Supplemental Agreement for work within scope P00003 · SOW revisions $4,782,644
Other Administrative Action P00002 $19,699,701
Exercise an Option P00001 · Exercise option 1 $0
Original award Development of an anti-sudan ebolavirus medical countermeasure $14,845,177
Show all 27

About this award

The Office of the Assistant Secretary for Preparedness and Response awarded a $62.5 million definitive contract to Mapp Biopharmaceutical, Inc. for development of an anti-Sudan Ebolavirus medical countermeasure on September 25, 2018, under cost-plus-fixed-fee pricing with no set-aside.

Place of performance is San Diego, CA. The contract's ultimate completion date is December 31, 2024.

As of the most recent reported fiscal year (FY2024), the contract carried a labor footprint of 1.3 FTEs across 2,701 contractor hours invoiced at a blended rate of $1,513.98 per hour, with 5 subcontractors accounting for approximately 3 percent of contractor hours. FY2024 invoiced $4.1 million. Prior-year labor declined substantially from FY2021 (12.0 FTEs, $15.4 million invoiced) and FY2022 (9.2 FTEs, $10.7 million invoiced), indicating significant wind-down of performance activity.

Quick answers

Who was awarded contract 75A50118C00024?

75A50118C00024 was awarded to Mapp Biopharmaceutical, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 25, 2018.

How much is contract 75A50118C00024 worth?

The government has obligated $56,704,950 on 75A50118C00024. Its potential value, with all options, is $62,511,942.

Was contract 75A50118C00024 competed?

The extent of competition for 75A50118C00024 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award